肠道菌群对南印度婴儿口服轮状病毒疫苗免疫原性的影响
在印度韦洛尔开展的巢式病例对照研究,比较325名婴儿接种两剂Rotarix后的肠道菌群与血清学应答。研究发现应答者在第一剂时更常携带至少一种细菌性肠道病原体(26% vs 13%,P=0.006),但第二剂时无此差异;第一剂后轮状病毒排毒与同时接种的口服脊髓灰质炎疫苗(OPV)复制呈负相关。总体未发现16S菌群组成或多样性与血清学应答的稳定关联。
要点
- 应答者第一剂时携带至少一种细菌性肠道病原体的比例高于无应答者(26% vs 13%,P=0.006)。
- 第二剂时携带病原体比例在应答者与无应答者间无显著差异(24% vs 23%,P=0.790)。
- 第一剂后轮状病毒排毒与同时接种的OPV复制呈负相关。
核心结论
- 同时接种的OPV对第一剂Rotarix有抑制效应,与既往研究一致。
- 在OPV同时接种背景下,未发现疫苗接种时肠道菌群其他组分与Rotarix免疫原性之间有强关联。
研究设计与样本
- 在印度韦洛尔开展的巢式病例对照研究,嵌套于一项临床试验(CTRI/2012/05/002677)。
- 婴儿在6周和10周龄接种两剂Rotarix,比较血清学应答者与无应答者的肠道菌群。
- 采用单重实时PCR Taqman阵列卡(TAC)检测325名婴儿接种前粪便样本中40种细菌、病毒和真核病原体靶标。
- 对170名婴儿子集通过16S rRNA基因V4区测序评估细菌菌群组成。
主要发现
- 第一剂时,应答者携带至少一种细菌性肠道病原体的比例高于无应答者(26%[40/156] vs 13%[21/157],χ2,P=0.006)。
- 第二剂时,携带至少一种细菌性肠道病原体的比例在应答者与无应答者间无显著差异(24%[38/158] vs 23%[36/158],P=0.790)。
- 第一剂后轮状病毒排毒与同时接种的OPV复制呈负相关。
- 未观察到16S细菌菌群组成或多样性随血清学应答出现一致差异,尽管轮状病毒排毒与接种前略多的细菌分类群相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oral rotavirus vaccines have consistently proven to be less immunogenic among infants in developing countries. Discrepancies in the intestinal microbiota, including a greater burden of enteropathogens and an altered commensal community composition, may contribute to this trend by inhibiting the replication of vaccine viruses. To test this possibility, we performed a nested case-control study in Vellore, India, in which we compared the intestinal microbiota of infants who responded serologically or not after two doses of Rotarix delivered at 6 and 10 weeks of age as part of a clinical trial (CTRI/2012/05/002677). The prevalence of 40 bacterial, viral, and eukaryotic pathogen targets was assessed in pre-vaccination stool samples from 325 infants using singleplex real-time PCR on a Taqman array card (TAC). In a subset of 170 infants, we assessed bacterial microbiota composition by sequencing the 16S rRNA gene V4 region. Contrary to expectations, responders were more likely than non-responders to harbor ≥1 bacterial enteropathogen at dose 1 (26% [40/156] vs 13% [21/157] of infants with TAC results who completed the study per protocol; χ2, P = .006), although this was not apparent at dose 2 (24% [38/158] vs 23% [36/158]; P = .790). Rotavirus shedding after dose 1 was negatively correlated with the replication of co-administered oral poliovirus vaccine (OPV). We observed no consistent differences in composition or diversity of the 16S bacterial microbiota according to serological response, although rotavirus shedding was associated with slightly more bacterial taxa pre-vaccination. Overall, our findings demonstrate an inhibitory effect of co-administered OPV on the first dose of Rotarix, consistent with previous studies, but in the context of OPV co-administration we did not find a strong association between other components of the intestinal microbiota at the time of vaccination and Rotarix immunogenicity.
引用
- Parker EPK, Praharaj I, Zekavati A, et al. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India. Vaccine. 2017. PMID: 29217369. doi:10.1016/j.vaccine.2017.11.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。